New Results from the National Health and Wellness Survey Show Awareness Is Lowest in Japan and Brazil
NEW YORK, October 18, 2012—Many patients who screen positive for major depressive disorder (MDD) do not self-report that they are suffering from depression, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health. The NHWS measures patient responses to health-related questions to determine whether they have MDD in the United States, the top five European countries, which include France, Germany, Italy, Spain and the UK (5EU), Brazil, Japan and Russia.
The percentage of adults who screen positive for MDD ranges from 4.5% in Japan to 9.8% in Brazil, but self-reporting is low at 27% in Japan and 43% in Brazil. In the U.S., Russia and 5EU awareness is much higher among those who screen positive for MDD at 64%, 54% and 51%, respectively.
“MDD has been cited as one of the leading causes of disabilities worldwide; it decreases a person’s ability to function and leads to other medical problems,” said Michael Fronstin, General Manager, Health Outcomes, at Kantar Health. “The MDD population is relatively young, so early diagnosis and adequate support could result in better long-term health outcomes.”
MDD sufferers are more aware of and report higher levels of insomnia, anxiety and pain, and they tend to be younger than patients without MDD. People who screen positive for MDD report significantly more hospitalizations and visits to the emergency room than people without MDD. Their mental quality of life is significantly lower compared with the general population, with scores ranging from 28.5 in Japan (versus 47.8 for the general Japanese population) to 35.4 in Brazil (versus 46.9 in the general Brazilian population).
“Effective and affordable treatments for depression are available, even in emerging markets,” Fronstin said. “Educating patients on the symptoms of MDD may raise their awareness and encourage them to visit their healthcare provider and receive appropriate treatment.”
For more information on the effect of MDD on patients’ health, download our infographic, “A Global Crisis: Depression is often unrecognized, undiagnosed and untreated.”
About the National Health and Wellness Survey (NHWS)
The study’s results were drawn from the 2011 5EU, U.S., Brazil, Japan and Russia NHWS, a nationally representative, self-administered survey conducted annually. Topics covered include the health status, attitudes, behaviors and outcomes among adults 18 or older.
Kantar Health conducts NHWS annually in the U.S., Europe, Asia and Latin America. The survey is the largest self-reported database in the healthcare industry.
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With staff in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Stacy Sevcik, Marketing Manager, at firstname.lastname@example.org or +1-314-529-3062.